AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$413M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$335M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$311M |
| 5 |
Microsoft
MSFT
|
+$303M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$260M |
| 2 |
Medtronic
MDT
|
+$239M |
| 3 |
T-Mobile US
TMUS
|
+$221M |
| 4 |
CELG
Celgene Corp
CELG
|
+$204M |
| 5 |
Nike
NKE
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Financials | 15.59% |
| 3 | Healthcare | 14.73% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ROAN
3076
DELISTED
Roan Resources, Inc.
ROAN
| $103K | ﹤0.01% |
59,385
+45,900
| +340% | +$166K |
|
3077
Vipshop
VIPS
$7.3B
| $102K | ﹤0.01% |
11,793
-396,330
| -97% | -$3.2M |
|
|
VRN
3078
DELISTED
Veren
VRN
| $102K | ﹤0.01% |
30,765
| – | – |
|
3079
Celestica
CLS
$40.5B
| $101K | ﹤0.01% |
14,789
-280
| -2% | -$2.04K |
|
3080
KALA BIO
KALA
$13.6M
| $100K | ﹤0.01% |
+6
| New | +$99.4K |
|
|
TTSH
3081
DELISTED
Tile Shop Holdings
TTSH
| $100K | ﹤0.01% |
25,030
+14,900
| +147% | +$70.8K |
|
|
PVG
3082
DELISTED
PRETIUM RESOURCES INC.
PVG
| $100K | ﹤0.01% |
+10,000
| New | +$84.9K |
|
3083
AXT Inc
AXTI
$3.07B
| $99K | ﹤0.01% |
24,900
+3,100
| +14% | +$14.5K |
|
|
BDSI
3084
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $99K | ﹤0.01% |
+21,300
| New | +$99.2K |
|
3085
Comstock Resources
CRK
$3.73B
| $94K | ﹤0.01% |
+16,800
| New | +$97.5K |
|
|
AMRS
3086
DELISTED
Amyris Inc.
AMRS
| $94K | ﹤0.01% |
26,300
+13,200
| +101% | +$52K |
|
|
SNCR
3087
DELISTED
Synchronoss Technologies
SNCR
| $93K | ﹤0.01% |
+1,300
| New | +$73.4K |
|
3088
eGain
EGAN
$183M
| $92K | ﹤0.01% |
11,300
+1,200
| +12% | +$10.9K |
|
|
EVLO
3089
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $92K | ﹤0.01% |
515
+10
| +2% | +$1.62K |
|
3090
ADMA Biologics
ADMA
$2.01B
| $91K | ﹤0.01% |
+23,600
| New | +$104K |
|
|
APHA
3091
DELISTED
Aphria Inc. Common Shares
APHA
| $91K | ﹤0.01% |
13,000
+2,700
| +26% | +$20.4K |
|
|
GNC
3092
DELISTED
GNC Holdings, Inc.
GNC
| $90K | ﹤0.01% |
59,802
+2
| +0% | +$4 |
|
|
CMCM
3093
Cheetah Mobile
CMCM
$88.5M
| $89K | ﹤0.01% |
+5,040
| New | +$132K |
|
|
EGLE
3094
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $88K | ﹤0.01% |
2,400
+314
| +15% | +$11.1K |
|
3095
Forte Biosciences
FBRX
$1.58B
| $86K | ﹤0.01% |
+34
| New | +$101K |
|
3096
Valhi
VHI
$391M
| $86K | ﹤0.01% |
2,425
+425
| +21% | +$11.9K |
|
|
CTST
3097
DELISTED
CannTrust Holdings Inc. Common Share
CTST
| $86K | ﹤0.01% |
+17,100
| New | +$105K |
|
|
TYME
3098
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $84K | ﹤0.01% |
68,800
+9,900
| +17% | +$13.9K |
|
3099
Hudbay
HBM
$10.1B
| $82K | ﹤0.01% |
15,100
+3,000
| +25% | +$17.8K |
|
|
KZR
3100
DELISTED
Kezar Life Sciences
KZR
| $82K | ﹤0.01% |
+1,070
| New | +$166K |
|
Similar funds
AllianceBernstein's Q2 2019 Portfolio in Review
As of Q2 2019, AllianceBernstein held 3,270 positions worth $161B, up 4.8% from $154B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AllianceBernstein's Q2 2019 filing shows 163 new, 1,818 increased, 1,043 reduced and 130 closed positions. Its largest new stake was Smartsheet Inc.: 1,910,302 shares worth $92.5M. The largest sale was Apple, an estimated $260M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q2 2019 buy was Smartsheet Inc.: 1,910,302 shares worth $92.5M.
- AllianceBernstein added most to UnitedHealth in Q2 2019, an estimated $413M increase.
- AllianceBernstein's biggest Q2 2019 reduction was Apple, cutting an estimated $260M.
- AllianceBernstein fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2019, selling an estimated $177M.
- AllianceBernstein's ten largest holdings make up 18% of its $161B portfolio in Q2 2019.
- AllianceBernstein opened 163 new positions and closed 130 in Q2 2019.
- AllianceBernstein's portfolio value rose 4.8% quarter-over-quarter to $161B.
Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.